EX-Fusion is Japan’s only private company dedicated to the commercialization of laser fusion reactors. This breakthrough technology has the potential to replace conventional energy sources and play a vital role in achieving carbon neutrality by 2050.
A startup has developed a painless, simple test using tears to detect cancer early and monitor for recurrence. Using cutting-edge technology originating from Kobe University, it enables highly sensitive detection of extracellular vesicles, allowing testing in everyday settings like homes or pharmacies.
A startup advancing drug discovery through proprietary platform technology that selectively delivers drugs to immune cells, both through in-house development and collaborative partnerships. It aims to create novel therapies for intractable diseases by controlling immune responses.
A startup manufacturing high-quality GeO2 substrates for next-generation power semiconductors that reduce power loss using proprietary technology. It provides stable supply of materials that were previously difficult to obtain, supporting efficient power conversion for realizing GX.
A tech-bio startup leveraging antibody big data and AI to tackle the challenges of drug discovery: identifying unresolved diseases and undiscovered target molecules. Breaking through the barriers of bio-data to pioneer new therapies.